Literature DB >> 25673782

Low prevalence of diabetes mellitus in patients with Takotsubo syndrome: A plausible 'protective' effect with pathophysiologic connotations.

John E Madias1.   

Abstract

AIMS: The pathophysiology of Takotsubo syndrome is still elusive; coronary vasospasm, microvascular dysfunction, or catecholamine-mediated injury to the cardiomyocytes, effected by local release from the autonomic nerves and/or blood-borne catecholamines, are considered as tentative cause(s). Diabetes mellitus-induced autonomic neuropathy leads to a brain-heart disconnection, and it can conceivably ameliorate/block the effect of an unbridled adrenergic storm to the heart, and the emergence of Takotsubo syndrome. This study sought to evaluate the prevalence of diabetes mellitus in patients with Takotsubo syndrome. METHODS AND
RESULTS: All the papers accessed in PubMed were reviewed, to evaluate the prevalence of diabetes mellitus and hypertension in Takotsubo syndrome patients, employing the rate of the latter as an index of how representative of the general population were the study patients, and the rate of the former as the focus of this investigation. Out of the 1932 papers, 959 were suitable for analysis, reporting on 33,894 patients (88.9% women) with Takotsubo syndrome. In five subanalyses, of all patients, patients reported individually, patients reported collectively in case series, patients ⩾ 60 years old reported individually, and patients ⩾ 65 years old reported individually, the prevalence of hypertension was 57.4%, 42.8%, 57.9%, 50.4%, and 52.2%, correspondingly, and comparable to the 65.4% shown by the National Health and Nutrition Examination Survey (NHANES). The prevalence of diabetes mellitus in the five subgroups was 16.8%, 10.2%, 17.0%, 11.9%, and 12.5%, correspondingly, and lower than the 26.9% found by the NHANES.
CONCLUSION: The prevalence of diabetes mellitus in patients with Takotsubo syndrome is low. This insight may be useful for the diagnosis, pathophysiology unraveling, and employment of autonomic adrenergic blocking agents in the management of patients with Takotsubo syndrome. © The European Society of Cardiology 2015.

Entities:  

Keywords:  Takotsubo syndrome; adrenal catecholamine secretion in diabetes mellitus; autonomic nervous system; diabetes mellitus; diabetic neuropathy

Mesh:

Year:  2015        PMID: 25673782     DOI: 10.1177/2048872615570761

Source DB:  PubMed          Journal:  Eur Heart J Acute Cardiovasc Care        ISSN: 2048-8726


  19 in total

1.  Autonomic nervous system and a 'vascular phase' in Takotsubo syndrome pathogenesis.

Authors:  John E Madias
Journal:  Nat Rev Cardiol       Date:  2015-06-16       Impact factor: 32.419

Review 2.  Autonomic nervous system in Takotsubo syndrome.

Authors:  Sonia Borodzicz; Katarzyna Czarzasta; Grzegorz Opolski; Agnieszka Cudnoch-Jędrzejewska
Journal:  Heart Fail Rev       Date:  2019-01       Impact factor: 4.214

3.  Trends in hospitalization for takotsubo cardiomyopathy in the United States.

Authors:  Rohan Khera; KellyAnn Light-McGroary; Firas Zahr; Phillip A Horwitz; Saket Girotra
Journal:  Am Heart J       Date:  2015-11-14       Impact factor: 4.749

Review 4.  Insulin and takotsubo syndrome: plausible pathophysiologic, diagnostic, prognostic, and therapeutic roles.

Authors:  John E Madias
Journal:  Acta Diabetol       Date:  2021-04-02       Impact factor: 4.280

Review 5.  Takotsubo syndrome: Advances in the understanding and management of an enigmatic stress cardiomyopathy.

Authors:  Hernán David Mejía-Rentería; Iván J Núñez-Gil
Journal:  World J Cardiol       Date:  2016-07-26

Review 6.  Left Ventricular Dysfunction in the Setting of Takotsubo Cardiomyopathy: A Review of Clinical Patterns and Practical Implications.

Authors:  Kenan Yalta; Mustafa Yilmaztepe; Cafer Zorkun
Journal:  Card Fail Rev       Date:  2018-05

7.  Tako-tsubo cardiomyopathy in a radical operation for carcinoma of colon patient with PCI history.

Authors:  Xin Gao; Xue-Dong Gan
Journal:  J Geriatr Cardiol       Date:  2017-08       Impact factor: 3.327

Review 8.  Epidemiology, pathogenesis, and management of takotsubo syndrome.

Authors:  Shams Y-Hassan; Per Tornvall
Journal:  Clin Auton Res       Date:  2017-09-15       Impact factor: 4.435

9.  Diabetes prevalence in patients with takotsubo syndrome in a Polish cohort: the meaning of 'controls'.

Authors:  J E Madias
Journal:  Neth Heart J       Date:  2017-03       Impact factor: 2.380

10.  Comment on "DKA-Induced Takotsubo Cardiomyopathy in Patient with Known HOCM".

Authors:  John E Madias
Journal:  Case Rep Crit Care       Date:  2017-11-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.